Anders Bjartell
91 – 100 of 372
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial
- Contribution to journal › Article
-
Mark
IMAGINE—IMpact Assessment of Guidelines Implementation and Education : The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines
- Contribution to journal › Debate/Note/Editorial
-
Mark
Diagnostic and prognostic factors in patients with prostate cancer : A systematic review protocol
- Contribution to journal › Scientific review
-
Mark
Bringing onco‐innovation to Europe’s healthcare systems : The potential of biomarker testing, real world evidence, tumour agnostic therapies to empower personalised medicine
- Contribution to journal › Article
-
Mark
The prognostic impact of the tumour stroma fraction : A machine learning-based analysis in 16 human solid tumour types
- Contribution to journal › Article
-
Mark
Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
- Contribution to journal › Article
-
Mark
Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance
- Contribution to journal › Article
-
Mark
Quantification of microRNA editing using two-tailed RT-qPCR for improved biomarker discovery
- Contribution to journal › Article
-
Mark
Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer : 8-Year Follow-up
- Contribution to journal › Article
-
Mark
Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer : Analysis of Pain and Fatigue in the Phase 3 TITAN Study
- Contribution to journal › Article
